LTR 135: Allison Komiyama on Rethinking Benefit-Risk in MedTech
Let's Talk Risk! Podcast
- Published
- December 5, 2025
- Duration
- 32:05
- Summary source
- description
- Last updated
- Apr 29, 2026
Discusses Summary“We talk about risk all the time, but we forget to talk about the benefit. FDA’s job is to pr…
Summary
Summary“We talk about risk all the time, but we forget to talk about the benefit. FDA’s job is to protect and promote public health, and benefit–risk is how those two missions meet.”In this episode of the Let's Talk Risk Podcast, host Naveen Agarwal sits down with Dr. Allison Komiyama, neuroscientist, former FDA reviewer, regulatory strategist, and founde…
Show notes
Summary“We talk about risk all the time, but we forget to talk about the benefit. FDA’s job is to protect and promote public health, and benefit–risk is how those two missions meet.”In this episode of the Let's Talk Risk Podcast, host Naveen Agarwal sits down with Dr. Allison Komiyama, neuroscientist, former FDA reviewer, regulatory strategist, and founder of Bluestocking Health. Known for her ability to make complex FDA topics understandable and fun, Allison brings fresh clarity to one of the m